TCA
CL icon

Transcend Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Transcend Capital Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
12,855
+1,272
+11% +$111K 0.08% 230
2026
Q1 		$987K Buy
11,583
+1,767
+18% +$157K 0.08% 232
2025
Q4 		$776K Sell
9,816
-440
-4% -$34.5K 0.06% 279
2025
Q3 		$820K Sell
10,256
-325
-3% -$27.7K 0.06% 285
2025
Q2 		$962K Sell
10,581
-7,924
-43% -$723K 0.07% 241
2025
Q1 		$1.73M Buy
18,505
+477
+3% +$42.7K 0.12% 178
2024
Q4 		$1.64M Sell
18,028
-421
-2% -$40.2K 0.12% 179
2024
Q3 		$1.92M Sell
18,449
-539
-3% -$54.9K 0.13% 176
2024
Q2 		$1.84M Buy
18,988
+26
+0.1% +$2.4K 0.13% 165
2024
Q1 		$1.71M Sell
18,962
-72
-0.4% -$6.1K 0.14% 165
2023
Q4 		$1.52M Buy
19,034
+3
+0% +$226 0.13% 166
2023
Q3 		$1.35M Sell
19,031
-2,356
-11% -$176K 0.13% 164
2023
Q2 		$1.65M Sell
21,387
-208
-1% -$16.1K 0.16% 150
2023
Q1 		$1.62M Sell
21,595
-748
-3% -$55.6K 0.17% 140
2022
Q4 		$1.76M Sell
22,343
-506
-2% -$37.9K 0.19% 128
2022
Q3 		$1.6M Buy
22,849
+1,282
+6% +$101K 0.18% 137
2022
Q2 		$1.73M Buy
21,567
+1,208
+6% +$94.5K 0.18% 135
2022
Q1 		$1.54M Sell
20,359
-60
-0.3% -$4.75K 0.14% 166
2021
Q4 		$1.74M Sell
20,419
-29
-0.1% -$2.27K 0.15% 154
2021
Q3 		$1.56M Sell
20,448
-1,001
-5% -$79.5K 0.14% 160
2021
Q2 		$1.74M Buy
21,449
+1,422
+7% +$116K 0.25% 100
2021
Q1 		$1.58M Sell
20,027
-294
-1% -$23K 0.19% 124
2020
Q4 		$1.74M Buy
20,321
+8,530
+72% +$705K 0.23% 109
2020
Q3 		$910K Buy
11,791
+771
+7% +$58.8K 0.17% 123
2020
Q2 		$807K Buy
11,020
+5,342
+94% +$379K 0.26% 84
2020
Q1 		$381K Buy
+5,678
New +$400K 0.11% 159

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Transcend Capital Advisors's CL Position: Q2 2026 in Review

Transcend Capital Advisors increased its Colgate-Palmolive (CL) stake by 11% in Q2 2026, buying an estimated $111K and bringing the position to 12,855 shares worth $1.18M. The position accounts for 0.08% of the portfolio, ranked #230.

Transcend Capital Advisors first reported a position in CL in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.92M in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Transcend Capital Advisors held 12,855 shares of Colgate-Palmolive worth $1.18M as of Q2 2026.
  • Transcend Capital Advisors bought 1,272 Colgate-Palmolive shares in Q2 2026, an estimated $111K.
  • Colgate-Palmolive made up 0.08% of Transcend Capital Advisors's portfolio in Q2 2026, its #230 holding.
  • Transcend Capital Advisors first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 26 quarters since.
  • Transcend Capital Advisors's Colgate-Palmolive position peaked at $1.92M in Q3 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.